Internal Medicine, Gastroenterology · Joliet, IL
NPI
1194022541
Since 2011
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
7
Medicare group memberships
Hospitals
2
Hospital affiliations
330 Madison St Ste 200
Joliet, IL, 60435
Phone (630) 717-2600
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
773 services
Medicare patients, 2024
329
Average age 74
Drug cost, 2024
$271K
1,106 prescriptions
Company payments, 2025
$350
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Faizan A Khan was code 99233 (hospital e&m - subsequent), 122 times for 68 patients. In total Faizan A Khan billed 773 services in 52 codes, and Medicare paid $88K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 122 | 68 | $95.08 | $12K |
| 99214 Office E&M - Established | Office | 85 | 68 | $88.94 | $7,560 |
| 99204 Office E&M - New | Office | 82 | 82 | $123.46 | $10K |
| 99222 Hospital E&M - Initial | Facility | 81 | 78 | $103.88 | $8,414 |
| 43239 Upper GI Endoscopy | Facility | 37 | 36 | $80.99 | $2,997 |
| 45385 Colonoscopy - Lesion Removal | Office | 30 | 29 | $396.25 | $12K |
| 45385 Colonoscopy - Lesion Removal | Facility | 27 | 26 | $215.60 | $5,821 |
| 43239 Upper GI Endoscopy | Office | 26 | 26 | $236.77 | $6,156 |
| 99232 Hospital E&M - Subsequent | Facility | 23 | 12 | $61.60 | $1,417 |
| 36415 Venipuncture Blood Collection | Office | 23 | 21 | $8.65 | $199 |
| 45380 Lower GI Endoscopy - Other | Office | 21 | 21 | $316.02 | $6,636 |
| 43235 Upper GI Endoscopy | Facility | 20 | 19 | $78.15 | $1,563 |
| 88305 Surgical Pathology Examination | Office | 20 | 11 | $29.31 | $586 |
| 45380 Lower GI Endoscopy - Other | Facility | 16 | 16 | $100.93 | $1,615 |
| 99221 Hospital E&M - Initial | Facility | 12 | 12 | $60.31 | $724 |
By year: 2022 $81K for 652 services; 2023 $113K for 801 services; 2024 $88K for 773 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 23 | 21 | $8.65 | $199 |
| 88305 Surgical Pathology Examination | 20 | 11 | $29.31 | $586 |
Medicare prescription drug claims, 2024
In 2024, the drug Faizan A Khan prescribed most often to Medicare patients was Pantoprazole Sodium, with 313 prescriptions and refills. In total Faizan A Khan wrote 1,106 Medicare prescriptions that cost $271K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 313 | 711 | 144 | $3,690 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 125 | 125 | 123 | $1,787 |
| Dicyclomine Hcl Generic | 83 | 91 | 34 | $860 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 74 | 74 | 73 | $1,151 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 49 | 49 | 49 | $999 |
| Cholestyramine Light Cholestyramine | 37 | 91 | 21 | $4,979 |
| Linzess Linaclotide | 33 | 63 | 15 | $33K |
| Nortriptyline Hcl Generic | 24 | 45 | Under 11 | $326 |
| Omeprazole Generic | 21 | 62 | Under 11 | $266 |
| Balsalazide Disodium Generic | 21 | 35 | Under 11 | $2,237 |
| Mesalamine Generic | 19 | 43 | Under 11 | $4,583 |
| Creon Lipase/Protease/Amylase | 18 | 26 | Under 11 | $44K |
| Trulance Plecanatide | 17 | 29 | Under 11 | $15K |
| Ondansetron Hcl Generic | 16 | 16 | Under 11 | $154 |
| Budesonide Dr Budesonide | 15 | 30 | Under 11 | $1,342 |
Brand drugs: 219 claims; generic drugs: 887 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Faizan A Khan $350 ($350 in general payments such as food, travel and fees) from 6 companies. The largest payer was Janssen Biotech, Inc. with $179.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.